Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Vitamin D Repletion Does Not Alter Urinary Calcium Excretion In Healthy Postmenopausal Women
UroToday.com - Vitamin D needs, especially in the northern latitudes where direct sunlight is unavailable for much of the year, are currently under scrutiny by members of both the scientific and medical communities. Vitamin D primarily plays a role in regulating calcium absorption in the gastrointestinal tract. However, epidemiologic and laboratory studies support the notion that vitamin D might play a role in chemoprevention - particularly of cancers of the colon, breast, ovarian, and prostate (Garland et al., Am J Public Health 2006;96:252-61) - immune modulation and prevention of certain autoimmune disorders (Cantorna et al., Exp Biol Med 2004;229:1136-1142), promoting bone integrity and preserving muscle mass (Montero-Odasso et al., Mol Aspects Med 2005;26:203-19), cardiovascular disease prevention (Wang et al., Circulation 2008;117:503-11), and prevention of all-cause mortality (Melamed et al., Arch Intern Med 2008;168:1629-37).

'Pro-choice Community' Should Find New 'Way Of Talking About Reproductive Freedom,' Opinion Piece Says
"Most of the push-back" from antiabortion-rights advocates to a recent e-mail message from author Judy Blume on behalf of Planned Parenthood -- which asked mailing list subscribers for donations -- was generated by an article in the antiabortion-rights publication LifeNews, columnist Meghan Daum writes in a Los Angeles Times opinion piece. The article put a "heavy, misrepresentative spin" on Blume"s message, which urged donors to "do all [they] can to support" the increasing number of women turning to Planned Parenthood centers for health care during the economic downturn.The LifeNews article said, "Blume notes how more women are seeking abortions from Planned Parenthood because of the difficult economy, and she urges readers of the e-mail to use that as a reason to support the abortion business." According to Daum, "this is just the kind of thing that makes abortion-rights advocates apoplectic," noting that abortion-rights advocates "fired-back" in the "blogosphere ... imparting the statistic about abortion making up only 3% of Planned Parenthood"s services and pointing out that many of the women being yelled at by picketers in clinic parking lots aren"t even pregnant but, rather, trying to avoid getting pregnant." Daum continues that the organization, much like Blume, "occupies a clear position on the post-Roe cultural map," adding, "Generally speaking, if you"re on board with abortion rights, you"re on board with Planned Parenthood." In addition, if you are against abortion rights, the "organization is the headquarters of Godlessness," she adds. Daum writes that it is not difficult to see why Planned Parenthood enlisted Blume -- an "icon of 1970s-era feminism and its efforts on behalf of sex education and women"s health" -- because she conjures "nostalgia for the early days of the fight that makes pro-choicers want to keep fighting today."Daum writes that as she watched this "saga unfold in [her] inbox," she was "struck by a troubling question. Even though Blume may not be associated with abortion in and of itself … is there something about her persona that signals a lack of dispassion about its ramifications? Is she reminding people of a time when, in the relief of Roe being decided, there was a cultural perception that abortion was a simple procedure that needn"t come with attendant emotional baggage?"Daum adds that there is "no denying that the language and overall tone around abortion has changed. Despite what many pro-life groups seem to think, most abortion-rights advocates prefer "safe, legal and rare" to "no big deal."" According to Daum, President Obama, "pro-choice though he is, is hardly strident -- and even a little evasive -- on the issue." She adds that Obama favors language about reducing the need for abortions and "finding common ground with the other side." Daum notes that the pop cultural arena "has become downright allergic to the issue" of abortion, with a recent movie coining the term "shmashmortion" because the characters "can"t even get the word out." Daum adds that although Blume "was undoubtedly effective" at bringing in funding for Planned Parenthood, perhaps what might have been "even more radical is if the pro-choice community could find a way of talking about reproductive freedom that neither reverts to the perceived casualness of the 1970s nor panders to the "shmashmortion" dialect of today. "Safe, legal and rare" comes close. But "safe, legal, rare and a big deal" might be even better" (Daum, Los Angeles Times, 5/14).
News of the day
Baylor Health Care System Receives $8M From French Government To Develop HIV Treatment
The French government has awarded Baylor Health Care System with an $8 million grant to develop a therapeutic method of controlling HIV without medication, the Dallas Morning News reports. The funds will go toward establishing an HIV research unit at Baylor"s Institute of Immunology Research, which will focus on researching the immune system cells of people living with HIV (Roberson, Dallas Morning News, 6/17).
Oncology

GSK Opens Pneumonia Vaccine Plant In Singapore

Drug maker GlaxoSmithKline (GSK) on Tuesday opened a $600 million plant in Singapore that is slated to begin producing vaccines to fight pneumonia-causing bacteria in 2011, Reuters reports. According to Reuters, the "vaccine protects infants and children under age 2 from the bacterium streptococcus pneumoniae, which causes diseases like pneumonia, meningitis, bronchitis, acute sinusitis and inflammation of the inner layer of the heart or endocarditis." These diseases kill almost one million children annually, and 90 percent of the deaths occur in developing countries. The pneumococcal conjugate vaccine was introduced in the U.S. in 2000, resulting in a "sharp drop in pneumococcal disease in children," Reuters reports. However, it is not yet available in many developing countries because the cost is prohibitive. GSK CEO Andrew Witty said the company"s new price flexibility policy would make its vaccines and other treatments more affordable for people in developing countries. Witty said it will take "a year or two" to make sure the "production processes [in the new plant] are running at the appropriate level of quality" (Wong-Anan, Reuters, 6/9). According to the Straits Times, these processes include visits from international health authority auditor teams, including the FDA and the WHO (Khalik, Straits Times, 6/10). GSK has a site in Belgium that also manufactures the vaccine (Reuters, 6/9). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009